Eli Lilly & Co. vs. Schrodinger, Inc. Common Stock
Eli Lilly & Co. (LLY) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| LLY | SDGR | |
|---|---|---|
| Market Cap | $1.01 trillion | $1.79 billion |
| Revenue (TTM) | $79.67 billion | $259.04 million |
| Net Income (TTM) | $26.71 billion | $-54,335,000 |
LLY leads on 3 of 3 size & scale factors.
Valuation
| LLY | SDGR | |
|---|---|---|
| P/E Ratio | 38.48 | — |
| Price / Book | 29.94 | 5.44 |
| Price / Sales | 12.73 | 6.91 |
SDGR leads on 2 of 2 valuation factors.
Profitability
| LLY | SDGR | |
|---|---|---|
| Net Margin | 33.53% | -20.98% |
| Return on Equity | 78.84% | -16.52% |
LLY leads on 2 of 2 profitability factors.
Dividend
| LLY | SDGR | |
|---|---|---|
| Dividend Yield | 0.60% | — |
| Payout Ratio | 23.23 | — |
LLY and SDGR split the dividend factors evenly.
Risk & Sentiment
| LLY | SDGR | |
|---|---|---|
| Short Interest | 1.29% | 0.11% |
SDGR leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, SDGR overview, SDGR financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.